The study on the fluorescence of mithramycin -: DNA and chromomycin-A3 -: ADN systems

被引:0
|
作者
Vijan, LE [1 ]
机构
[1] Univ Pitesti, Fac Stiinte, Pitesti 110040, Romania
来源
REVISTA DE CHIMIE | 2005年 / 56卷 / 06期
关键词
mithramycin; chromomycin A(3); calf thymus DNA; fluorescence spectroscopy;
D O I
暂无
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
The interaction of two related anticancer drugs belonging to the aureolic family of antibiotics, mithramycin and chromomycin A(3), with calf thymus DNA was studied by fluorescence spectroscopy. The positive curvatures of the Stern-Volmer plots obtained for both drugs in the presence of DNA could be due to a static quenching by an association process. The results were rationalized in terms of the Schatchard, Schwarz and Watanabe models, in order to obtain the binding constants of drugs to DNA and the number of binding sites. For both drugs two processes were evidenced At little polymer-drug ratios (P/D) were found cooperative binding constants of 2,1(.)10(5)M(-1) for mithramycin and 1,9(.)10(5)M(-1) for chromomycin A(3). The binding constants of 3,1(.)10(5)M(-1) for mithramycin and 2,8(.)10(5)M(-1) for chromomycin A(3) and a low cooperativity characterize the process evidenced at higher ratios.
引用
收藏
页码:655 / 658
页数:4
相关论文
共 50 条
  • [1] THE BIOSYNTHESIS OF CHROMOMYCIN-A3
    MONTANARI, A
    ROSAZZA, JPN
    TETRAHEDRON LETTERS, 1988, 29 (43) : 5513 - 5516
  • [2] NMR INVESTIGATION OF MITHRAMYCIN-A BINDING TO D(ATGCAT)2 - A COMPARATIVE-STUDY WITH CHROMOMYCIN-A3
    BANVILLE, DL
    KENIRY, MA
    SHAFER, RH
    BIOCHEMISTRY, 1990, 29 (39) : 9294 - 9304
  • [3] THE STRUCTURE OF CHROMOMYCIN-A3
    MIYAMOTO, M
    MORITA, K
    KAWAMATSU, Y
    SASAI, M
    NOHARA, A
    TANAKA, K
    TATSUOKA, S
    NAKANISHI, K
    NAKADAIRA, Y
    BHACCA, NS
    TETRAHEDRON LETTERS, 1964, (33-4) : 2367 - 2370
  • [4] CHROMOMYCINONE, THE AGLYCONE OF CHROMOMYCIN-A3
    MIYAMOTO, M
    MORITA, K
    KAWAMATSU, Y
    NOGUCHI, S
    MARUMOTO, R
    TANAKA, K
    TATSUOKA, S
    NAKANISHI, K
    NAKADAIRA, Y
    BHACCA, NS
    TETRAHEDRON LETTERS, 1964, (33-4) : 2355 - 2365
  • [5] NMR-STUDIES OF CHROMOMYCIN-A3 INTERACTION WITH DNA
    BERMAN, E
    BROWN, SC
    JAMES, TL
    SHAFER, RH
    BIOCHEMISTRY, 1985, 24 (24) : 6887 - 6893
  • [6] SPECIES-SPECIFIC DIFFERENCES IN THE TOXICITY AND MUTAGENICITY OF THE ANTICANCER DRUGS MITHRAMYCIN, CHROMOMYCIN-A3, AND OLIVOMYCIN
    SINGH, B
    GUPTA, RS
    CANCER RESEARCH, 1985, 45 (06) : 2813 - 2820
  • [7] PHARMACOKINETIC STUDY OF CHROMOMYCIN-A3 (TOYOMYCIN) THERAPY
    MORGAN, LR
    HAGARDORN, AN
    MADDUX, B
    CARTER, DR
    KREMENTZ, ET
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1974, 15 (MAR): : 143 - 143
  • [9] CHROMOMYCIN-A3 - PHASE-2 STUDY IN CHILDHOOD MALIGNANCIES
    KRIVIT, W
    SONLEY, M
    SMITH, WB
    HIGGINS, G
    WEINER, J
    HAMMOND, D
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1976, 17 (MAR): : 176 - 176
  • [10] ROLE OF MAGNESIUM-ION IN THE INTERACTION BETWEEN CHROMOMYCIN-A3 AND DNA - BINDING OF CHROMOMYCIN-A3-MG2+ COMPLEXES WITH DNA
    AICH, P
    SEN, R
    DASGUPTA, D
    BIOCHEMISTRY, 1992, 31 (11) : 2988 - 2997